Zug
Switzerland
4
2018-12-20
2
2020-07-14
These are the the leading inventors for applications assigned to OTOLANUM AG:
OTOLANUM AG based in Zug, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#2 | 2018-08-02 โ Patent 10,456,386 granted on 2019-10-29Pharmaceutical composition comprising betahistine
#3 | 2015-04-09PHANTOM PHENOMENA TREATMENT
#4 | 2015-02-12TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
Also check out Otolanum AG's (Zug, Switzerland) applicant profile with 2 patent applications submitted.
87725 โ